TMEM85 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.365000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.848990E-01
Normal-vs-Stage2
2.763000E-01
Normal-vs-Stage3
6.619400E-01
Normal-vs-Stage4
3.325600E-01
Stage1-vs-Stage2
4.255800E-01
Stage1-vs-Stage3
5.380600E-01
Stage1-vs-Stage4
4.228400E-01
Stage2-vs-Stage3
7.104800E-01
Stage2-vs-Stage4
7.470600E-01
Stage3-vs-Stage4
9.739000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.323200E-01
Normal-vs-AfricanAmerican
1.154820E-01
Normal-vs-Asian
4.753600E-01
Caucasian-vs-AfricanAmerican
3.920200E-01
Caucasian-vs-Asian
4.080600E-01
AfricanAmerican-vs-Asian
8.157400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.198000E-01
Normal-vs-Female
1.599010E-01
Male-vs-Female
1.479650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.619000E-01
Normal-vs-Age(41-60Yrs)
8.232200E-02
Normal-vs-Age(61-80Yrs)
3.687400E-01
Normal-vs-Age(81-100Yrs)
4.943700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.174000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.854400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.552200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.783600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.309800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.417600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.220600E-01
Normal-vs-Daily Drinker
2.010800E-01
Normal-vs-Weekly Drinker
3.031600E-01
Normal-vs-Occasional Drinker
1.472580E-01
Normal-vs-Social Drinker
2.615400E-01
Non Drinker-vs-Daily Drinker
4.401200E-01
Non Drinker-vs-Weekly Drinker
9.783400E-01
Non Drinker-vs-Occasional Drinker
2.815400E-01
Non Drinker-vs-Social Drinker
9.295600E-01
Daily Drinker-vs-Weekly Drinker
4.466400E-01
Daily Drinker-vs-Occasional Drinker
7.137600E-01
Daily Drinker-vs-Social Drinker
3.833800E-01
Weekly Drinker-vs-Occasional Drinker
2.789600E-01
Weekly Drinker-vs-Social Drinker
9.467200E-01
Occasional Drinker-vs-Social Drinker
2.243400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.168760E-01
Normal-vs-Grade 2
5.317600E-01
Normal-vs-Grade 3
5.135200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.125000E-01
Grade 1-vs-Grade 3
1.622750E-01
Grade 1-vs-Grade 4
1.168760E-01
Grade 2-vs-Grade 3
5.603000E-01
Grade 2-vs-Grade 4
5.317600E-01
Grade 3-vs-Grade 4
5.135200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.336400E-01
Normal-vs-NonDiabetic
1.394200E-01
Diabetic-vs-NonDiabetic
1.231370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.386400E-02
Normal-vs-NoPancreatitis
2.247000E-01
Pancreatitis-vs-NoPancreatitis
2.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.260800E-01
Normal-vs-N1
2.719000E-01
N0-vs-N1
6.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.662400E-02
Normal-vs-TP53-NonMutant
5.564800E-01
TP53-Mutant-vs-TP53-NonMutant
5.90419999999536E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
